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eding  caused  by  GAVE.  Our  cases  did  not  present  with
mplications.
We  can  conclude  that  APE  in  children  with  GAVE,  as  in
ults,  is  useful  for  controlling  active  bleeding,  without
using  serious  complications.  The  pathology  should  be  sus-
cted  in  children  presenting  with  gastrointestinal  bleeding
t  causes  anemia,  who  are  undergoing  treatment  with
munosuppressants  and/or  have  an  autoimmune  disease.
psy  may  not  always  report  vascular  lesions.  An  endo-
pic  image  characteristic  of  GVE  with  no  other  etiology
 gastrointestinal  bleeding  that  responds  favorably  to  APE
atment  supports  the  diagnosis.  GAVE  should  be  consid-
d  a  cause  of  gastrointestinal  bleeding  in  the  pediatric
pulation.
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esophagogastroduodenoscopy  (EGD)  are  the  diagnostic
methods  of  choice,  but  repeat  studies  may  be  required
for  conﬁrmation.5 Endoscopic  treatment  of  recurrent  TEF
has  been  described  as  a  therapeutic  alternative  to  repeat
open  chest  surgery  repair.  Some  studies  have  reported  on
the
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atamiento endoscópico de fístula
aqueoesofágica recurrente con una
mbinación de N-butyl-2-cianocrilato
istoacryl®) y lipiodol por esofagoscopia
 pediatría
current  tracheoesophageal  ﬁstulas  (TEFs)  may  present
1.9  to  20%  of  cases  after  surgical  primary  closure  in
tients  with  esophageal  atresia  (EA)  and  TEF.1--3 Respi-
ory  symptoms  of  chronic  cough,  episodes  of  choking
d/or  cyanosis  after  eating,  recurrent  pneumonia,  chronic
g  disease,  and  malnutrition  should  lead  to  diagnos-
 suspicion.1,4,5 Upper  gastrointestinal  series  (UGI)  andPlease cite this article as: Cadena-León JF, Quimbayo-Wilches
, Ramírez-Mayans JA, Cervantes-Bustamante R, Toro-Monjaraz
. Tratamiento endoscópico de fístula traqueoesofágica recur-
te con una combinación de N-butyl-2-cianocrilato (Histoacryl®)
ipiodol por esofagoscopia en pediatría. Revista de Gastroen-
ología de México. 2016;81:233--235.
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ye use  of  tissue  adhesives  such  as  N-butyl-cyanoacrylate
istoacryl®),  ﬁbrin  or  sclerosing  agents,  and  laser.1--3 We
scribe  herein  the  case  of  a  preschool  child  with  recurrent
F  managed  with  a  combination  of  Histoacryl® and  lipiodol
 esophageal  endoscopy.5
A  3-year-old  girl  was  delivered  by  cesarean  section  at
 weeks  of  gestation,  G2,  weighing  1.5  kg,  and  measuring
 cm.  She  had  a past  history  of  severe  oligohydramnios,
rauterine  growth  retardation,  and  umbilical  catheter-
tion.  She  underwent  esophagoplasty  at  5  days  of  life
th  ﬁstula  closure  due  to  type  III  EA  and  TEF  at  another
titution.  At  19  months  of  age  the  patient  was  referred  to
 Gastroenterology  and  Nutrition  Service  of  our  hospital
cause  of  upper  gastrointestinal  bleeding  causing  anemia.
e  was  diagnosed  with  grade  III  esophageal  varices  sec-
dary  to  portal  hypertension  and  cavernous  transformation
the  portal  vein  and  was  managed  with  endoscopic  variceal
nd  ligation  and  sclerotherapy  with  no  complications.
rting  at  24  months  of  life,  the  patient  presented  with
ptoms  of  repeat  pneumonia,  gastroesophageal  reﬂux,
nchial  hyperreactivity,  esophageal  candidiasis,  pediatric
ronic  lung  disease,  and  chronic  malnutrition,  meriting
merous  hospitalizations  and  the  use  of  proton  pump
ibitors,  inhaled  steroids,  and  short-acting  bronchodila-
s.  An  EGD  was  performed  when  the  patient  was  3
ars  old,  identifying  the  TEF  opening  at  16  cm  from  the
234  S
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fFigure  1  Endoscopic  image  of  the  tracheoesophageal  ﬁstu
prior to  treatment.
incisors  and  grade  II  esophageal  varices.  An  esophagogra
revealed  a  short  1.5  cm  recurrent  TEF.  Endoscopy  wit
Olympus® GIF-Q150  equipment  was  programmed,  appl
ing  a  mixture  of  Histoacryl® (0.5  ml)  and  lipiodol  (0.5  m
with  an  Olympus® sclerotherapy  catheter-needle  (180  cm
2.3  mm)  through  the  opening  of  the  ﬁstula  from  th
distal  to  the  proximal  segment  without  completely  co
ering  the  edge.  There  were  no  reported  complication
The  quantity  of  the  sclerosing  agent  was  calculated  b
the  size  of  the  ﬁstula  as  seen  in  the  esophagogra
(1.5  cm).
With  the  patient  in  a  fasting  state,  an  esophagogram  wa
carried  out  7  days  after  the  procedure  with  no  signs  of  ﬁstu
and  an  EGD  was  performed  at  15  days.  During  the  24-mont
follow-up  period  there  were  no  new  hospitalizations,  symp
toms  of  pneumonia,  or  episodes  of  choking  during  eatin
The  use  of  bronchodilators  and  inhaled  steroids  was  reduce
and  nutritional  status  improved  (Figs.  1  and  2).
The  endoscopic  treatment  of  recurrent  TEFs  utilizing  th
tissue  adhesive  Histoacryl® as  a  therapeutic  alternative  t
surgical  reintervention  due  to  its  morbidity  and  morta
ity  was  ﬁrst  described  in  the  1970s.6 Recurrent  TEFs  ma
Table  1  Endoscopic  treatment  of  the  TEF  via  the  esopha
literature.
First  author  Material  utilized  Number  o
patientsDaniel8
(1980)
Cyanoacrylate  1  
Al-Samarrai9
(1987)
Cyanoacrylate  1  
Vandenplas7
(1993)
Aethoxysklerol  +
cyanoacrylate
1  
Yankovic10
(2009)
Argon  plasma  6  
Source: modiﬁed table of Meier et al.3SCIENTIFIC  LETTER
Figure  2  Endoscopic  image  of  tracheoesophageal  ﬁstula  aft
treatment.
present  months  or  years  after  surgery,  and  respiratory  symp
toms,  chronic  lung  disease,  and  malnutrition  should  lead  t
diagnostic  suspicion.  There  are  still  few  reports  of  cases  
pediatrics  and  they  mainly  involve  the  use  of  bronchoscop
and  a  fewer  number  of  esophagoscopies.
Three  modalities  of  endoscopic  treatment  have  bee
described:  1)  injection  of  tissue  adhesive  (67%  success  rate
2)  de-epithelization  of  the  mucosa  (14%  success  rate),  an
3)  combination  of  de-epithelization  and  tissue  adhesive  (39
success  rate).2
According  to  reports  in  the  literature,  the  number  of  se
sions  required  for  achieving  successful  closure  varies  from
to  4 (Table  1).  The  use  of  Histoacryl® via  esophagoscopy  fo
recurrent  TEF  management  has  been  described  in  pediatric
with  a  good  success  rate2 (Table  1).
Vandenplas  et  al.  reported  on  a  12-year-old  fema
patient  with  TEF  managed  with  a  combination  of  Histoacry
and  Aethoxysklerol®,  achieving  successful  closure  in  
esophagoscopy  sessions.7
The  success  rate  of  recurrent  TEF  endoscopic  treatmen
has  been  reported  at  39-48%  with  a  ﬁrst  session  and  60-81
with  2  sessions  or  more.1,3
Success  rate  and  number  of  sessions.  A  review  of  the  medical
Number  of
procedures
Closure  success
percentage
Follow-up
in months1  0  1.5
1  100  3
4  100  12
2.6  66  41
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In  the  case  of  our  patient,  we  used  a  combination  of
toacryl® and  lipiodol.  The  latter  is  useful  for  evaluating
mplications  associated  with  the  application  of  cyanoacry-
e,  for  radiographic  control  (embolisms  and  perforations),
d  for  achieving  polymerization  of  the  tissue  adhesive
10-12  seconds.  A  single  session  was  performed  with  no
-epithelization  of  the  edges  of  the  mucosa  and  no  appar-
t  complications  at  the  24-month  follow-up.  Associated
mplications  are  respiratory  difﬁculty  and  death  in  1.7%
the  cases.2
The  risk  for  reﬁstulization  after  the  procedure  may
sent  in  up  to  63%  of  the  cases,  requiring  1-6  procedures
 successful  closure  and  in  some  cases  a  second  surgical
ervention  is  necessary.  Therefore,  patient  selection  and
low-up  are  important.  Up  to  the  present,  our  patient  has
d  no  ﬁstula  recurrence.
The  diagnosis  of  recurrent  TEF  is  a  challenge  for  the
ending  physician,  and  by  virtue  of  clinical  suspicion,  EGD
d  endoscopy  are  required  for  conﬁrming  the  diagnosis.
doscopic  treatment  with  tissue  adhesives  is  an  option  in
ected  patients  presenting  with  greater  morbidity  and  in
om  surgical  intervention  involves  a  greater  risk.
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